S Kalyanasundaram, former managing director of GlaxoSmithKline Pharmaceuticals, will join Sun Pharmaceutical Industries, the country’s largest drug manufacturer in terms of market capitalisation, as one of its top three executives.
He is head, commercial excellence, for the Asia-Pacific region of GSK, the world’s second largest drug company. Sources said Sun Pharma has not yet finalised the role and designation of his responsibilities, but he will join by April.
Sun Pharma’s day to day operations are mainly headed by Dilip Shanghvi, chairman and managing director, and Sudhir Valia, whole time director.
Kalyanasundaram, known in industry circles as Kal, was appointed GSK’s managing director in 2003, succeeding V Thyagarajan.
A science graduate from Madurai University and a qualified chartered accountant, Kalyanasundaram had joined Wellcome as a commercial advisor in New Zealand in 1988.
